Ticker Symbol: ATHX
Athersys Inc
$1.25 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001368148
Company Profile
athersys is a clinical stage biopharmaceutical company with a growing pipeline of highly differentiated, potential best in class therapeutics to treat significant and life-threatening diseases. we are engaged in the discovery and development of innovative new medicines designed to extend and enhance the quality of human life. through the application of our proprietary technologies, we have established a pipeline of therapeutic product development programs in multiple disease areas. this pipeline includes both stem cell therapy and pharmaceuticals.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 3201 Carnegie Ave
Website: http://www.athersys.com/
CEO: Gil Van Bokkelen
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 17, 2023 03:00 PM EST
Previous Close: $0.10
Change:
$0.00
(
3.77%)
Days Range: $0.02 - $0.10
Beta: -
52wk. High: -
52wk. Low: -
Ytd. Change 3.77%
50 Day Moving Average: -
200 Day Moving Average: -
Shares Outstanding: 22501410
Valuation
Market Cap: 229.1M
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A